Cargando…
A case report of Phelan-McDermid syndrome: preliminary results of the treatment with growth hormone therapy
BACKGROUND: Phelan-McDermid syndrome (PMS), also known as 22q13.3 deletion syndrome, is a rare neurodevelopmental syndrome resulting from a deletion of the distal long arm of chromosome 22. CASE PRESENTATION: We report a case of a 21 months old Chinese girl presenting with global developmental delay...
Autores principales: | Xie, Rui Jin, Li, Tian Xiao, Sun, Chenyu, Cheng, Ce, Zhao, Jinlin, Xu, Hua, Liu, Yueying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7934562/ https://www.ncbi.nlm.nih.gov/pubmed/33663540 http://dx.doi.org/10.1186/s13052-021-01003-w |
Ejemplares similares
-
Correction to: A case report of Phelan-McDermid syndrome: preliminary results of the treatment with growth hormone therapy
por: Xie, Rui Jin, et al.
Publicado: (2021) -
Effectiveness of Recombinant Human Growth Hormone Therapy for Children With Phelan-McDermid Syndrome: An Open-Label, Cross-Over, Preliminary Study
por: Li, TianXiao, et al.
Publicado: (2022) -
Understanding Behavior in Phelan-McDermid Syndrome
por: Landlust, Annemiek M., et al.
Publicado: (2022) -
Characterisation of the clinical phenotype in Phelan-McDermid syndrome
por: Burdeus-Olavarrieta, Mónica, et al.
Publicado: (2021) -
A proof-of-concept study of growth hormone in children with Phelan–McDermid syndrome
por: Sethuram, S., et al.
Publicado: (2022)